Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.

Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.

Item
http://www.wikidata.org/entity/Q42816694
Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertilityRevealing a steroid receptor ligand as a unique PPARγ agonistStructure of a 13-fold superhelix (almost) determined from first principles.RU486 did not exacerbate cytokine release in mice challenged with LPS nor in db/db mice.Assessing the metabolic effects of prednisolone in healthy volunteers using urine metabolic profiling.Liver-specific overexpression of pancreatic-derived factor (PANDER) induces fasting hyperglycemia in miceGlucocorticoids produce whole body insulin resistance with changes in cardiac metabolism.Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.Thermogenic and metabolic antiobesity drugs: rationale and opportunities.Phosphatidyl inositol 3-kinase signaling in hypothalamic proopiomelanocortin neurons contributes to the regulation of glucose homeostasis.PANcreatic-DERived factor: novel hormone PANDERing to glucose regulation.Epigenomic and transcriptional control of insulin resistance.Human aging in the post-GWAS era: further insights reveal potential regulatory variants.Quantitative analysis of RU38486 (mifepristone) by HPLC triple quadrupole mass spectrometry.Acute interaction between hydrocortisone and insulin alters the plasma metabolome in humansNon-steroidal glucocorticoid receptor antagonists: the race to replace RU-486 for anti-glucocorticoid therapy.Combretum lanceolatum flowers ethanol extract inhibits hepatic gluconeogenesis: an in vivo mechanism study.
P2860

Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.

Item
http://www.wikidata.org/entity/Q42816694
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Hepatic glucocorticoid recepto ...... mal models of type 2 diabetes.
@en
Hepatic glucocorticoid recepto ...... mal models of type 2 diabetes.
@nl
type
label
Hepatic glucocorticoid recepto ...... mal models of type 2 diabetes.
@en
Hepatic glucocorticoid recepto ...... mal models of type 2 diabetes.
@nl
prefLabel
Hepatic glucocorticoid recepto ...... mal models of type 2 diabetes.
@en
Hepatic glucocorticoid recepto ...... mal models of type 2 diabetes.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Hepatic glucocorticoid recepto ...... mal models of type 2 diabetes.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921